Global Aortic Endograft Industry Valuation to Reach USD 5,513.5 million by 2034 exhibit a CAGR of 4.9% Amid Rising Prevalence of Aortic Aneurysms | FMI

Aortic Endograft Industry
Aortic Endograft Industry

The global aortic endograft industry was valued at around USD 3,255.5 million in 2023 and is anticipated to exhibit a CAGR of 4.9% over the forecast period. Accordingly, total market revenue is set to grow from USD 3,430.3 million in 2024 to USD 5,513.5 million by 2034.

Several factors are expected to drive growth of the aortic endograft industry during the assessment period. These include growing incidence of aortic aneurysms and increasing popularity of minimally invasive procedures.

The surge in the incidence rate of lifestyle diseases is a key driving force behind the growth of the aortic endograft market. Similarly, the increasing geriatric population will likely uplift aortic endograft demand.

Track the Latest Market Developments: Request a Sample Report! https://www.futuremarketinsights.com/report-sample#5245502d47422d3138373336

Lifestyle diseases, including hypertension, atherosclerosis, and diabetes, contribute to the development of aortic pathologies such as abdominal aortic aneurysms (AAA) and thoracic aortic aneurysms (TAA). This demographic shift, characterized by a rising prevalence of risk factors and an aging population, has created a substantial demand for advanced medical interventions, particularly aortic endografts.

Lifestyle diseases such as hypertension and atherosclerosis significantly increase the risk of aortic diseases. Persistent high blood pressure and the buildup of fatty deposits in the arteries contribute to the weakening and dilation of the aorta, leading to an increased incidence of aneurysms.

Diabetes, another lifestyle-related condition, is known to accelerate the progression of atherosclerosis and increase the risk of cardiovascular complications, including aortic diseases. The prevalence of diabetes is on the rise globally, further contributing to the burden of aortic pathologies.

The risk of developing aortic pathologies, including aneurysms, rises substantially with age. The natural aging process leads to changes in the structure and elasticity of the aorta, making it more susceptible to dilation and aneurysm formation.

The combination of a growing incidence of lifestyle diseases and an aging population suggests a sustained demand for aortic endografts in the future. As individuals live longer, the prevalence of aortic pathologies is likely to increase, necessitating advanced treatment options to address the specific needs of the elderly population.

Ongoing technological advancements significantly impact the aortic endograft industry. Innovations such as advanced materials, 3D printing, and robotic-assisted procedures enhance the safety and efficacy of aortic endograft interventions.

The continuous evolution of technology is expected to introduce more sophisticated and patient-specific solutions. These advancements can lead to improved outcomes, reduced complications, and expanded applications for aortic endografts.

Key Takeaways from the Market Study

  • The global market for aortic endografts is set to total USD 5,513.5 million by 2034.
  • By product, the abdominal aortic grafts segment is estimated to hold a value share of 8% in 2024.
  • By material, polymeric endografts segment is poised to grow at a CAGR of 3% through 2034.
  • By procedure, the endovascular aneurysm repair (EVAR) segment is set to expand at 5% CAGR between 2024 and 2034.
  • The United States aortic endograft market value is set to total USD 1,231.9 million in 2033.
  • Demand in India is projected to grow at a CAGR of 6% through 2034.

“Growing prevalence of aneurysms and rising geriatric population are key factors responsible for fueling growth of the aortic endograft market,” says an analyst of Future Market Insights (FMI).

Growing Need for Market Insights: Access Our Full Report for Thorough Analysis and Trends! https://www.futuremarketinsights.com/reports/aortic-endograft-market

Market Competition

Increasing new product launches and FDA approvals is the key strategy of leading manufacturers like Terumo Corporation and Braile Biomedica, among others, to enhance their presence in the market and compete with other competitors. Following are a few examples of key developments made by them to be at the top position:

  • In August 2020, Terumo Corporation Aortic announced that the TREO Abdominal Aortic Stent-Graft System has been approved for sale in the United States by the Food and Drug Administration (FDA) to treat patients with abdominal aortic aneurysms (AAA).
  • In August 2018, Rafael Braile, the Executive Director of Braile Biomedical, showcased the company’s brands at the India Valves 2018 event, which took place in India.

Key Companies Profiled:

Medtronic; Cook; W. L. Gore & Associates, Inc.; Braile Biomédica; Cordis Corporation; Endologix LLC; Endospan; LifeTech Scientific; MicroPort Scientific Corporation; Terumo Corporation

Key Market Segments Covered in Aortic Endograft Industry Research:

By Product:

  • Abdominal Aortic Grafts
  • Thoracic Aortic Grafts

By Material:

  • Metallic Endografts
    • Stainless Steel
    • Nitinol
  • Polymeric Endografts
    • Dacron
    • ePTFE

By Procedure:

  • Open Surgical Repair
  • Endovascular Aneurysm Repair (EVAR)
    • Standard EVAR
    • Fenestrated EVAR
    • Branched EVAR
    • TEVAR
    • Iliac branched EVAR
    • Chimney EVAR
    • Hybrid EVAR

By End User:

  • Hospitals
    • Private Hospitals
    • Public Hospitals
  • Ambulatory Surgical Centers

By Region:

  • United States
  • Japan
  • Europe
  • North America
  • Latin America
  • Asia Pacific Excluding Japan
  • Middle East & Africa

Request Your Free Healthcare Industry Analysis Today! https://www.futuremarketinsights.com/industry-analysis/therapeutic-device

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: 
sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube

Leave a comment

Your email address will not be published. Required fields are marked *